Krishna Institute of Medical Sciences Ltd - 543308 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release on the Unaudited Financial Results of the Company for the First Quarter ended 30 June 202110-08-2021
10-08-2021
Krishna Institute of Medical Sciences Ltd - 543308 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release on the Unaudited Financial Results of the Company for the First Quarter ended 30 June 202110-08-2021
Krishna Institute of Medical Sciences Ltd - 543308 - Unaudited Financial Results For The Quarter Ended June 30,2021
Pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Board of Directors have approved the unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended June 30, 2021 at their meeting held on August 10, 2021, which are enclosed herewith along with the Limited Review Reports issued by S.R. Batliboi & Associates LLP, the Statutory Auditors of the Company.10-08-2021
Krishna Institute of Medical Sciences Ltd - 543308 - Board Meeting Outcome for Outcome Of Board Meeting Held On 10Th August, 2021 Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
With reference to the subject, we enclose/furnish the following documents: a. The Unaudited Financial results (Both Standalone and Consolidated) for the 1st Quarter ended 30th June, 2021 together with Limited Review Report which has been reviewed by Audit Committee and approved by Board of Directors. b. The Financial results will also be published in the newspapers, in the format prescribed under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. c. The said documents are also being uploaded on the website of the Company i.e., www.kimshospitals.com10-08-2021
Krishna Institute of Medical Sciences Ltd - 543308 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Intimation about conference call for analysts and investors09-08-2021
Krishna Institute of Medical Sciences Ltd - 543308 - Board Meeting Intimation for For Approval Of The Unaudited Financial Results For The 1" Quarter Ended 30Th June, 2021
Krishna Institute Of Medical Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2021 ,inter alia, to consider and approve To consider and approve the following financial statements 1) Standalone and Consolidated financial results for the quarter ended 30 June, 2021 as reviewed by M/s. S. R. Batliboi & Associates LLP, statutory auditors of the Company 2) Standalone and Consolidated financial results for the quarter ended 30 June, 2020 as prepared by the management of the Company. 3) Standalone and Consolidated financial results for the quarter ended 31 March, 2021 as prepared by the management of the Company. 4) Any other item with the Permission of the Chair31-07-2021
Krishna Institute of Medical Sciences Ltd - 543308 - Shareholding for the Period Ended June 30, 2021
Krishna Institute of Medical Sciences Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2021. For more details, kindly Click here14-07-2021
Krishna Institute of Medical Sciences Ltd - 543308 - Statement Of Investor Complaints For The Quarter Ended June 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 050500 Name of the Signatory :- Umashankar ManthaDesignation :- Company Secretary and Compliance Officer14-07-2021
Krishna Institute of Medical Sciences Ltd - 543308 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on July 13, 2021 for Bhaskara Rao Bollineni13-07-2021
Krishna Institute of Medical Sciences Ltd - 543308 - Disclosure Of Related Party Transactions Pursuant To Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulation, 2015 ('Listing Regulations')
Pursuant to the provisions of SEBI (Listing Obligations & Disclosure Requirements)Regulations 2015 (as amended), every listed company shall submit within 30 days from the date of publication of its standalone and consolidated financials for the half year, disclosures of related party transactions on a consolidated basis. However, our Company, Krishna Institute of Medical Sciences Limited, got listed on the 28th June, 2021 and the Company had approved Annual Financial Statements in their Board Meeting held on 25th May, 2021 and based on email received from BSE dated 2nd July, 2021 directing our Company to file Annual Financials, we have filed the financials in XBRL Format and PDF format. Hence, our company is filing the related party transactions as required Regulation 23(9) of SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015 based on our Annual Financials.09-07-2021